Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manuel Praga

Showing results (11-20 of 265) with videos related to

Pageof 27
Sort By:
Current Hypertension Reports|January 20, 2012
The effect of weight loss in obesity and chronic kidney diseaseEnrique Morales, Manuel Praga
Current Opinion in Nephrology and Hypertension|August 18, 2006
Obesity, proteinuria and progression of renal failureManuel Praga, Enrique Morales
Kidney International|September 16, 2010
Obesity-related renal damage: changing diet to avoid progressionManuel Praga, Enrique Morales
Contributions to Nephrology|August 25, 2006
Weight loss and proteinuriaManuel Praga, Enrique Morales
Kidney International|March 26, 2010
Acute interstitial nephritisManuel Praga, Ester González
Clinical Journal of the American Society of Nephrology : CJASN|July 1, 2022
Prognostication for C3 Glomerulopathy and Idiopathic Immunoglobulin-Associated Membranoproliferative GlomerulonephritisFernando Caravaca-Fontán, Manuel Praga
Kidney International|February 21, 2026
The expanding role of complement inhibitors in the treatment of IgA nephropathyFernando Caravaca-Fontán, Manuel Praga
Nefrologia|December 12, 2017
Nephropathology and nephrology. The need for a changeEduardo Vazquez Martul, Manuel Praga
Nature Reviews. Nephrology|July 18, 2012
Glomerular disease: Predicting outcomes in idiopathic membranous nephropathyManuel Praga, Jorge Rojas-Rivera
Kidney360|September 30, 2022
Should Corticosteroids be Used To Treat Biopsy-Proven Drug-Induced Acute Interstitial Nephritis?: COMMENTARYManuel Praga, Fernando Caravaca-Fontán
Pageof 27

Showing results (11-20 of 265) with videos related to

Sort By:
Pageof 27
Current Hypertension Reports|January 20, 2012
The effect of weight loss in obesity and chronic kidney diseaseEnrique Morales, Manuel Praga
Current Opinion in Nephrology and Hypertension|August 18, 2006
Obesity, proteinuria and progression of renal failureManuel Praga, Enrique Morales
Kidney International|September 16, 2010
Obesity-related renal damage: changing diet to avoid progressionManuel Praga, Enrique Morales
Contributions to Nephrology|August 25, 2006
Weight loss and proteinuriaManuel Praga, Enrique Morales
Kidney International|March 26, 2010
Acute interstitial nephritisManuel Praga, Ester González
Clinical Journal of the American Society of Nephrology : CJASN|July 1, 2022
Prognostication for C3 Glomerulopathy and Idiopathic Immunoglobulin-Associated Membranoproliferative GlomerulonephritisFernando Caravaca-Fontán, Manuel Praga
Kidney International|February 21, 2026
The expanding role of complement inhibitors in the treatment of IgA nephropathyFernando Caravaca-Fontán, Manuel Praga
Nefrologia|December 12, 2017
Nephropathology and nephrology. The need for a changeEduardo Vazquez Martul, Manuel Praga
Nature Reviews. Nephrology|July 18, 2012
Glomerular disease: Predicting outcomes in idiopathic membranous nephropathyManuel Praga, Jorge Rojas-Rivera
Kidney360|September 30, 2022
Should Corticosteroids be Used To Treat Biopsy-Proven Drug-Induced Acute Interstitial Nephritis?: COMMENTARYManuel Praga, Fernando Caravaca-Fontán
Pageof 27